Recent movements like #MeToo and Time’s Up have pushed us to hold the perpetrators of sexual assault accountable. But the more we had admired the accused, the more reluctant we are to address the ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Grace Science, LLC announced today that the first patient was dosed in an open-label Phase 1/2/3 clinical trial of GS-100, an AAV9 gene replacement therapy for the ...
Michael Mahoney GS ’67, a dedicated professor of the history of science who spent 40 years at the University, died Wednesday, July 23, at the University Medical Center at Princeton. Mahoney was unable ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Grace Science, LLC announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GS-100, an investigational AAV9 gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results